Cargando…
CADM1 inhibits squamous cell carcinoma progression by reducing STAT3 activity
Although squamous cell carcinomas (SqCCs) of the lungs, head and neck, oesophagus, and cervix account for up to 30% of cancer deaths, the mechanisms that regulate disease progression remain incompletely understood. Here, we use gene transduction and human tumor xenograft assays to establish that the...
Autores principales: | Vallath, Sabari, Sage, Elizabeth K., Kolluri, Krishna K., Lourenco, Sofia N., Teixeira, Vitor S., Chimalapati, Suneeta, George, P. Jeremy, Janes, Sam M., Giangreco, Adam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4817512/ https://www.ncbi.nlm.nih.gov/pubmed/27035095 http://dx.doi.org/10.1038/srep24006 |
Ejemplares similares
-
Systemic but not topical TRAIL-expressing mesenchymal stem cells reduce tumour growth in malignant mesothelioma
por: Sage, Elizabeth K, et al.
Publicado: (2014) -
β-Catenin determines upper airway progenitor cell fate and preinvasive squamous lung cancer progression by modulating epithelial–mesenchymal transition
por: Giangreco, Adam, et al.
Publicado: (2012) -
Cryopreservation of human mesenchymal stromal cells expressing TRAIL for human anti-cancer therapy
por: Yuan, Zhengqiang, et al.
Publicado: (2016) -
Mesenchymal stromal cell delivery of full-length tumor necrosis factor–related apoptosis-inducing ligand is superior to soluble type for cancer therapy
por: Yuan, ZhengQiang, et al.
Publicado: (2015) -
LRIG1 regulates cadherin-dependent contact inhibition directing epithelial homeostasis and pre-invasive squamous cell carcinoma development
por: Lu, Liwen, et al.
Publicado: (2013)